Hansa Biopharma is a biopharmaceutical company that develops and markets immunomodulatory enzymes for the treatment of autoimmune diseases.
Business Model:
Revenue: $37.1M
Employees: 51-200
Address: P.O. Box 785
City: Lund
State: skåne län
Zip: 22007
Country: SE
Hansa Biopharma is a biopharmaceutical company that develops and markets immunomodulatory enzymes for the treatment of autoimmune diseases.
Contact Phone:
+14646165670
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
10/19/2007
Ticker Symbol:
HNSA
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2020 | Private Placement | $121M | 7/2022 | Grant | $0 |
Novaquest Capital Management Novaquest Capital Management |
11/2017 | Equity | $65M | 7/2022 | Grant | 1 | $70M |
Novaquest Capital Management Novaquest Capital Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|